Y
Yassmin Moatasim
Publications - 57
Citations - 1389
Yassmin Moatasim is an academic researcher. The author has contributed to research in topics: Medicine & Influenza A virus subtype H5N1. The author has an hindex of 13, co-authored 33 publications receiving 882 citations.
Papers
More filters
Journal ArticleDOI
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
Ranawaka A.P.M. Perera,Peigang Wang,Peigang Wang,Mokhtar R. Gomaa,Rabeh El-Shesheny,Ahmed Kandeil,Ola Bagato,Lewis Y. Siu,Mahmoud Shehata,Ahmed S. Kayed,Yassmin Moatasim,Ming Yuan Li,Leo L.M. Poon,Yi Guan,Richard J. Webby,Mohamed A. Ali,J. S. Peiris,Ghazi Kayali +17 more
TL;DR: The newly developed ppNT assay does not require Biosafety Level 3 containment and is thus a relatively high-throughput assay, well suited for large-scale seroepidemiology studies which are needed to better understand the ecology and epidemiology of MERS-CoV.
Journal ArticleDOI
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
Ahmed Mostafa,Ahmed Kandeil,Yaseen A.M.M. Elshaier,Omnia Kutkat,Yassmin Moatasim,Adel A. Rashad,Mahmoud Shehata,Mokhtar R. Gomaa,Noura Mahrous,Sara H. Mahmoud,Mohamed GabAllah,Hisham A. Abbas,Ahmed El Taweel,Ahmed E. Kayed,Mina Nabil Kamel,Mohamed El Sayes,Dina B. Mahmoud,Rabeh El-Shesheny,Ghazi Kayali,Mohamed A. Ali +19 more
TL;DR: It is shown that Azithromycin can selectively impair SARS-CoV-2 replication, but not the Middle East Respiratory Syndrome Coronavirus (MERS- coV), and the results suggest that Piroxicam should be prescribed in combination with Azathromycin for COVID-19 patients.
Journal ArticleDOI
Active Surveillance for Avian Influenza Virus, Egypt, 2010-2012
Ghazi Kayali,Ahmed Kandeil,Rabeh El-Shesheny,Ahmed S. Kayed,Mokhtar Gomaa,Asmaa M. Maatouq,Mahmoud Shehata,Yassmin Moatasim,Ola Bagato,Zhipeng Cai,Adam Rubrum,M. A. Kutkat,Pamela McKenzie,Robert G. Webster,Richard J. Webby,Mohamed A. Ali +15 more
TL;DR: Genetic and antigenic analyses of viruses revealed that influenza A(H5N1) clade 2.2.1 viruses are dominant and that all subtype H9N2 viruses are G1-like, which poses concern for potential reassortment.
Journal ArticleDOI
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
Mohamed A. Ali,Mahmoud Shehata,Mokhtar R. Gomaa,Ahmed Kandeil,Rabeh El-Shesheny,Ahmed S. Kayed,Ahmed Nageh El-Taweel,Mohamed Atea,Nagla Hassan,Ola Bagato,Yassmin Moatasim,Sara H. Mahmoud,Omnia Kutkat,Asmaa M. Maatouq,Ahmed Osman,Pamela McKenzie,Richard J. Webby,Ghazi Kayali +17 more
TL;DR: The hypothesis that camels are a reservoir for MERS-CoV and that camel trade is an important route of introducing the virus into importing countries is supported and findings related to waning antibodies and re-infection have implications for camel vaccine development, disease management and zoonotic threat.
Journal ArticleDOI
Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013
Ahmed Kandeil,Rabeh El-Shesheny,Asmaa M. Maatouq,Yassmin Moatasim,Mahmoud Shehata,Ola Bagato,Adam Rubrum,Karthik Shanmuganatham,Richard J. Webby,Mohamed A. Ali,Ghazi Kayali +10 more
TL;DR: Serological analysis of H9N2 virus revealed antigenic conservation among Egyptian isolates, and continuous surveillance that results in genetic and antigenic characterization of H5N1 subtype in Egypt is warranted.